HARVARD BIOSCIENCE INC - Common Stock, par value $0.01 per share (HBIO)
CUSIP: 416906105
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.01 per share
- Shares outstanding
- 5,297,433
- Total 13F shares
- 18,909,639
- Share change
- -6,669,672
- Total reported value
- $8,390,056
- Put/Call ratio
- 22%
- Price per share
- $0.44
- Number of holders
- 63
- Value change
- -$3,556,213
- Number of buys
- 32
- Number of sells
- 62
Quarterly Holders Quick Answers
What is CUSIP 416906105?
CUSIP 416906105 identifies HBIO - HARVARD BIOSCIENCE INC - Common Stock, par value $0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 416906105:
Top shareholders of HBIO - HARVARD BIOSCIENCE INC - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Bertrand Loy |
3/4/5
|
Director |
—
class O/S missing
|
556,208
|
$2,286,015 | — | 21 May 2024 | |
| AMH Equity Ltd |
13F
|
Company |
64%
|
3,387,355
|
$1,917,243 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
2.5%
from 13D/G
|
2,820,462
|
$1,596,382 | — | 31 Mar 2025 | |
| Michael A. Rossi |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
260,540
|
$1,393,889 | — | 29 Dec 2022 | |
| Harvey Partners, LLC |
13F
13D/G
|
Company |
5%
from 13D/G
|
2,187,500
|
$1,238,125 | — | 31 Mar 2025 | |
| WEBER CAPITAL MANAGEMENT LLC /ADV |
13D/G
|
Weber Capital Management, LLC |
7.3%
|
3,200,380
|
$1,216,144 | +$259,711 | 31 Mar 2025 | |
| Thomas W. Loewald |
3/4/5
|
Director |
—
class O/S missing
|
295,311
|
$1,213,728 | — | 21 May 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
40%
|
2,138,749
|
$1,210,532 | — | 31 Mar 2025 | |
| Alan I. Edrick |
3/4/5
|
Director |
—
class O/S missing
|
273,911
|
$1,125,774 | — | 21 May 2024 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
34%
|
1,777,894
|
$1,006,288 | — | 31 Mar 2025 | |
| Granahan Investment Management, LLC |
13F
|
Company |
29%
|
1,527,894
|
$864,788 | — | 31 Mar 2025 | |
| Kenneth Fletcher Olson |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
155,595
|
$832,433 | — | 29 Dec 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
27%
|
1,437,808
|
$813,906 | — | 31 Mar 2025 | |
| HEARTLAND ADVISORS INC |
13F
|
Company |
21%
|
1,108,578
|
$627,455 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
20%
|
1,077,069
|
$606,000 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
17%
|
923,061
|
$522,523 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
17%
|
883,698
|
$500,173 | — | 31 Mar 2025 | |
| Meros Investment Management, LP |
13F
|
Company |
15%
|
794,680
|
$449,789 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
14%
|
745,235
|
$421,803 | — | 31 Mar 2025 | |
| Acuitas Investments, LLC |
13F
|
Company |
9.3%
|
491,092
|
$277,958 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
7.9%
|
418,614
|
$236,936 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
6.2%
|
329,964
|
$186,759 | — | 31 Mar 2025 | |
| BARD ASSOCIATES INC |
13F
|
Company |
4.8%
|
251,849
|
$142,547 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
4%
|
209,548
|
$118,604 | — | 31 Mar 2025 | |
| STRS OHIO |
13F
|
Company |
3.9%
|
206,700
|
$116,992 | — | 31 Mar 2025 | |
| Pasadena Private Wealth, LLC |
13F
|
Company |
3.7%
|
198,039
|
$112,090 | — | 31 Mar 2025 | |
| Jennifer Cote |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
159,019
|
$109,500 | — | 19 Mar 2025 | |
| RBF Capital, LLC |
13F
|
Company |
3.4%
|
180,912
|
$102,396 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
3.3%
|
173,326
|
$98,103 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
3.2%
|
170,172
|
$96,317 | — | 31 Mar 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
3.2%
|
168,444
|
$95,000 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2.8%
|
146,305
|
$82,809 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
2.6%
|
139,999
|
$79,239 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
2.6%
|
135,556
|
$76,725 | — | 31 Mar 2025 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
2.3%
|
120,381
|
$68,136 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.9%
|
98,883
|
$55,968 | — | 31 Mar 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
89,517
|
$50,667 | — | 31 Mar 2025 | |
| GAMCO INVESTORS, INC. ET AL |
13F
|
Company |
1.6%
|
85,000
|
$48,110 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.6%
|
84,702
|
$47,941 | — | 31 Mar 2025 | |
| Williams & Novak, LLC |
13F
|
Company |
1.5%
|
77,770
|
$45,884 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.4%
|
75,985
|
$43,312 | — | 31 Mar 2025 | |
| GABELLI FUNDS LLC |
13F
|
Company |
1.2%
|
65,000
|
$36,790 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
1.2%
|
62,814
|
$35,553 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
1.2%
|
62,301
|
$35,262 | — | 31 Mar 2025 | |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
1.1%
|
58,947
|
$33,364 | — | 31 Mar 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
1%
|
54,426
|
$30,805 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.79%
|
41,762
|
$23,638 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.78%
|
41,396
|
$23,425 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.77%
|
40,943
|
$23,173 | — | 31 Mar 2025 | |
| INTECH INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.68%
|
35,911
|
$20,326 | — | 31 Mar 2025 |
Institutional Holders of HARVARD BIOSCIENCE INC - Common Stock, par value $0.01 per share (HBIO) as of Q2 2025
As of 30 Jun 2025,
HARVARD BIOSCIENCE INC - Common Stock, par value $0.01 per share (HBIO) was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,909,639 shares.
The largest 10 holders included
AMH Equity Ltd, Harvey Partners, LLC, VANGUARD GROUP INC, Granahan Investment Management, LLC, DIMENSIONAL FUND ADVISORS LP, BlackRock, Inc., ACADIAN ASSET MANAGEMENT LLC, Meros Investment Management, LP, UBS Group AG, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
64
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
88
Q2 2025 holders
63
Holder diff
-25
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.